S. Antinone, G. Shubeita, K. Coller, J. Lee, S. Haverlock-moyns et al., The Herpesvirus Capsid Surface Protein, VP26, and the Majority of the Tegument Proteins Are Dispensable for Capsid Transport toward the Nucleus, Journal of Virology, vol.80, issue.11, pp.5494-5498, 2006.
DOI : 10.1128/JVI.00026-06

P. Adusumilli, B. Stiles, M. Chan, M. Mullerad, D. Eisenberg et al., Imaging and therapy of malignant pleural mesothelioma using replication-competent herpes simplex viruses, The Journal of Gene Medicine, vol.158, issue.5, pp.603-615, 2006.
DOI : 10.1002/jgm.877

L. Le, H. Le, A. Nelson, D. Matthews, M. Yamamoto et al., Core labeling of adenovirus with EGFP, Virology, vol.351, issue.2, pp.291-302, 2006.
DOI : 10.1016/j.virol.2006.03.042

S. Finke, K. Brzozka, and K. Conzelmann, Tracking Fluorescence-Labeled Rabies Virus: Enhanced Green Fluorescent Protein-Tagged Phosphoprotein P Supports Virus Gene Expression and Formation of Infectious Particles, Journal of Virology, vol.78, issue.22, pp.12333-12343, 2004.
DOI : 10.1128/JVI.78.22.12333-12343.2004

B. Hernaez, J. Escribano, and C. Alonso, Visualization of the African swine fever virus infection in living cells by incorporation into the virus particle of green fluorescent protein-p54 membrane protein chimera, Virology, vol.350, issue.1, pp.1-14, 2006.
DOI : 10.1016/j.virol.2006.01.021

K. Page, T. Liegler, and M. Feinberg, Use of a Green Fluorescent Protein as a Marker for Human Immunodeficiency Virus Type 1 Infection, AIDS Research and Human Retroviruses, vol.13, issue.13, pp.1077-1081, 1997.
DOI : 10.1089/aid.1997.13.1077

A. Brown, S. Gartner, T. Kawano, N. Benoit, and C. Cheng-mayer, HLA-A2 down-regulation on primary human macrophages infected with an M-tropic EGFP-tagged HIV-1 reporter virus, Journal of Leukocyte Biology, vol.78, issue.3, pp.675-685, 2005.
DOI : 10.1189/jlb.0505237

B. Muller, J. Daecke, O. Fackler, M. Dittmar, H. Zentgraf et al., Construction and Characterization of a Fluorescently Labeled Infectious Human Immunodeficiency Virus Type 1 Derivative, Journal of Virology, vol.78, issue.19, pp.10803-10813, 2004.
DOI : 10.1128/JVI.78.19.10803-10813.2004

D. Mcdonald, M. Vodicka, G. Lucero, T. Svitkina, G. Borisy et al., Visualization of the intracellular behavior of HIV in living cells, The Journal of Cell Biology, vol.70, issue.3, pp.441-452, 2002.
DOI : 10.1128/JVI.75.2.759-771.2001

E. Schaeffer, R. Geleziunas, and W. Greene, Human Immunodeficiency Virus Type 1 Nef Functions at the Level of Virus Entry by Enhancing Cytoplasmic Delivery of Virions, Journal of Virology, vol.75, issue.6, pp.2993-3000, 2001.
DOI : 10.1128/JVI.75.6.2993-3000.2001

M. Pandori, N. Fitch, H. Craig, D. Richman, C. Spina et al., Producer-cell modification of human immunodeficiency virus type 1: Nef is a virion protein, J Virol, vol.70, pp.4283-4290, 1996.

R. Welker, H. Kottler, H. Kalbitzer, and H. Krausslich, Human Immunodeficiency Virus Type 1 Nef Protein Is Incorporated into Virus Particles and Specifically Cleaved by the Viral Proteinase, Virology, vol.219, issue.1, pp.228-236, 1996.
DOI : 10.1006/viro.1996.0240

A. Bukovsky, T. Dorfman, A. Weimann, and H. Gottlinger, Nef association with human immunodeficiency virus type 1 virions and cleavage by the viral protease, J Virol, vol.71, pp.1013-1018, 1997.

M. Bentham, S. Mazaleyrat, and M. Harris, Role of myristoylation and N-terminal basic residues in membrane association of the human immunodeficiency virus type 1 Nef protein, Journal of General Virology, vol.87, issue.3, pp.563-571, 2006.
DOI : 10.1099/vir.0.81200-0

S. Manes, R. Del, R. Lacalle, P. Lucas, C. Gomez-mouton et al., Membrane raft microdomains mediate lateral assemblies required for HIV-1 infection, EMBO reports, vol.10, issue.2, pp.190-196, 2000.
DOI : 10.1093/embo-reports/kvd025

J. Wang, E. Kiyokawa, E. Verdin, and D. Trono, The Nef protein of HIV-1 associates with rafts and primes T cells for activation, Proceedings of the National Academy of Sciences, vol.154, issue.5, pp.394-399, 2000.
DOI : 10.1016/0092-8674(90)90802-L

Y. Zheng, A. Plemenitas, T. Linnemann, O. Fackler, and B. Peterlin, Nef increases infectivity of HIV via lipid rafts, Current Biology, vol.11, issue.11, pp.875-879, 2001.
DOI : 10.1016/S0960-9822(01)00237-8

Y. Zheng, A. Plemenitas, C. Fielding, and B. Peterlin, Nef increases the synthesis of and transports cholesterol to lipid rafts and HIV-1 progeny virions, Proceedings of the National Academy of Sciences, vol.73, issue.3, pp.8460-8465, 2003.
DOI : 10.1128/JVI.75.6.2993-3000.2001

M. Alexander, Y. Bor, K. Ravichandran, M. Hammarskjold, and D. Rekosh, Human Immunodeficiency Virus Type 1 Nef Associates with Lipid Rafts To Downmodulate Cell Surface CD4 and Class I Major Histocompatibility Complex Expression and To Increase Viral Infectivity, Journal of Virology, vol.78, issue.4, pp.1685-1696, 2004.
DOI : 10.1128/JVI.78.4.1685-1696.2004

N. Sol-foulon, C. Esnault, Y. Percherancier, F. Porrot, P. Metais-cunha et al., The Effects of HIV-1 Nef on CD4 Surface Expression and Viral Infectivity in Lymphoid Cells Are Independent of Rafts, Journal of Biological Chemistry, vol.279, issue.30, pp.31398-31408, 2004.
DOI : 10.1074/jbc.M401621200

URL : https://hal.archives-ouvertes.fr/pasteur-01372660

S. Peretti, I. Schiavoni, K. Pugliese, and M. Federico, Cell Death Induced by the Herpes Simplex Virus-1 Thymidine Kinase Delivered by Human Immunodeficiency Virus-1-Based Virus-like Particles, Molecular Therapy, vol.12, issue.6, pp.1185-1196, 2005.
DOI : 10.1016/j.ymthe.2005.06.474

E. Krautkramer, S. Giese, J. Gasteier, W. Muranyi, and O. Fackler, Human Immunodeficiency Virus Type 1 Nef Activates p21-Activated Kinase via Recruitment into Lipid Rafts, Journal of Virology, vol.78, issue.8, pp.4085-4097, 2004.
DOI : 10.1128/JVI.78.8.4085-4097.2004

S. Sparacio, T. Pfeiffer, H. Schaal, and V. Bosch, Generation of a Flexible Cell Line with Regulatable, High-Level Expression of HIV Gag/Pol Particles Capable of Packaging HIV-Derived Vectors, Molecular Therapy, vol.3, issue.4, pp.602-612, 2001.
DOI : 10.1006/mthe.2001.0296

A. Pacchia, S. Mukherjee, and J. Dougherty, Choice and Use of Appropriate Packaging Cell Types, Methods Mol Biol, vol.229, pp.29-42, 2003.
DOI : 10.1385/1-59259-393-3:29

M. Greenberg, S. Bronson, M. Lock, M. Neumann, G. Pavlakis et al., Co-localization of HIV-1 Nef with the AP-2 adaptor protein complex correlates with Nef-induced CD4 down-regulation, The EMBO Journal, vol.16, issue.23, pp.6964-6976, 1997.
DOI : 10.1093/emboj/16.23.6964

J. Briggs, M. Simon, I. Gross, H. Krausslich, S. Fuller et al., The stoichiometry of Gag protein in HIV-1, Nature Structural & Molecular Biology, vol.11, issue.7, pp.672-675, 2004.
DOI : 10.1128/JVI.75.6.2753-2764.2001

H. Lamparski, A. Metha-damani, J. Yao, S. Patel, D. Hsu et al., Production and characterization of clinical grade exosomes derived from dendritic cells, Journal of Immunological Methods, vol.270, issue.2, pp.211-226, 2002.
DOI : 10.1016/S0022-1759(02)00330-7

Y. Chen, D. Trono, and D. Camaur, The proteolytic cleavage of human immunodeficiency virus type I Nef does not correlate with its ability to stimulate virion infectivity, J Virol, vol.72, pp.3178-3184, 1998.

B. Fredericksen and M. Whitt, Vesicular stomatitis virus glycoprotein mutations that affect membrane fusion activity and abolish virus infectivity, J Virol, vol.69, pp.1435-1443, 1995.

S. Archer and R. Hodin, Histone acetylation and cancer, Current Opinion in Genetics & Development, vol.9, issue.2, pp.171-174, 1999.
DOI : 10.1016/S0959-437X(99)80026-4

P. Wade, D. Pruss, and A. Wolffe, Histone acetylation: chromatin in action, Trends in Biochemical Sciences, vol.22, issue.4, pp.128-132, 1997.
DOI : 10.1016/S0968-0004(97)01016-5

O. Fackler and B. Peterlin, Endocytic entry of HIV-1, Current Biology, vol.10, issue.16, pp.1005-1008, 2000.
DOI : 10.1016/S0960-9822(00)00654-0

B. Fredricksen, B. Wei, J. Yao, T. Luo, and J. Garcia, Inhibition of Endosomal/Lysosomal Degradation Increases the Infectivity of Human Immunodeficiency Virus, Journal of Virology, vol.76, issue.22, pp.11440-11446, 2002.
DOI : 10.1128/JVI.76.22.11440-11446.2002

B. Wei, P. Denton, O. Neill, E. Luo, T. Foster et al., Inhibition of Lysosome and Proteasome Function Enhances Human Immunodeficiency Virus Type 1 Infection, Journal of Virology, vol.79, issue.9
DOI : 10.1128/JVI.79.9.5705-5712.2005

L. Cocquerel, C. Voisset, and J. Dubuisson, Hepatitis C virus entry: potential receptors and their biological functions, Journal of General Virology, vol.87, issue.5, pp.1075-1084, 2006.
DOI : 10.1099/vir.0.81646-0

URL : https://hal.archives-ouvertes.fr/hal-00105501

F. Mavilio, G. Ferrari, S. Rossini, N. Nobili, C. Bonini et al., Peripheral blood lymphocytes as target cells of retroviral vector-mediated gene transfer, Blood, vol.83, pp.1988-1997, 1994.

T. Dull, R. Zufferey, M. Kelly, R. Mandel, M. Nguyen et al., A third-generation lentivirus vector with a conditional packaging system, J Virol, vol.72, pp.8463-8471, 1998.

G. Rossi, P. Verani, B. Macchi, M. Federico, A. Orecchia et al., Recovery of HIV-related Retroviruses From Italian Patients with AIDS or AIDS-related Complex and from Asymptomatic At-Risk Individuals, Annals of the New York Academy of Sciences, vol.2, issue.1 Normal and Ne, pp.390-400, 1987.
DOI : 10.1084/jem.154.6.1957

A. Adachi, H. Gendelman, S. Koenig, T. Folks, R. Willey et al., Production of acquired immunodeficiency syndromeassociated retrovirus in human and nonhuman cells transfected with an infectious molecular clone, J Virol, vol.59, pp.284-291, 1986.

M. Federico, Z. Percario, E. Olivetta, G. Fiorucci, C. Muratori et al., HIV-1 Nef activates STAT1 in human monocytes/macrophages through the release of soluble factors, Blood, vol.98, issue.9, pp.2752-2761, 2001.
DOI : 10.1182/blood.V98.9.2752